TOVX logo

Theriva Biologics (TOVX) Short Term Debt

Annual Short Term Debt

$550.00 K
+$277.00 K+101.47%

31 December 2023

TOVX Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Short Term Debt

$606.00 K
+$31.00 K+5.39%

01 September 2024

TOVX Quarterly Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TOVX Short Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+101.5%+15.2%
3 y3 years+91.6%+388.7%
5 y5 years+120.9%+143.4%

TOVX Short Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+343.6%at high+388.7%
5 y5 yearsat high+343.6%at high+388.7%
alltimeall time-86.3%-84.8%

Theriva Biologics Short Term Debt History

DateAnnualQuarterly
Sept 2024
-
$606.00 K(+5.4%)
June 2024
-
$575.00 K(+2.7%)
Mar 2024
-
$560.00 K(+1.8%)
Dec 2023
$550.00 K(+101.5%)
$550.00 K(+4.6%)
Sept 2023
-
$526.00 K(+1.3%)
June 2023
-
$519.00 K(+3.2%)
Mar 2023
-
$503.00 K(+84.2%)
Dec 2022
$273.00 K(+120.2%)
$273.00 K(+30.6%)
Sept 2022
-
$209.00 K(+13.6%)
June 2022
-
$184.00 K(-5.2%)
Mar 2022
-
$194.00 K(+56.5%)
Dec 2021
$124.00 K(-56.8%)
-
Dec 2021
-
$124.00 K(-29.1%)
Sept 2021
-
$175.00 K(-10.7%)
June 2021
-
$196.00 K(-34.0%)
Mar 2021
-
$297.00 K(+3.5%)
Dec 2020
$287.00 K(+15.3%)
$287.00 K(+3.2%)
Sept 2020
-
$278.00 K(+3.7%)
June 2020
-
$268.00 K(+3.9%)
Mar 2020
-
$258.00 K(+3.6%)
Dec 2019
$249.00 K(>+9900.0%)
$249.00 K(+3.3%)
Sept 2019
-
$241.00 K(+3.4%)
June 2019
-
$233.00 K(+3.6%)
Mar 2019
-
$225.00 K(>+9900.0%)
DateAnnualQuarterly
Dec 2018
$0.00(-100.0%)
$0.00(0.0%)
Sept 2011
-
$0.00(0.0%)
June 2011
-
$0.00(0.0%)
Mar 2011
-
$0.00(-100.0%)
Sept 2010
-
$17.00 K(0.0%)
June 2010
-
$17.00 K(0.0%)
Mar 2010
-
$17.00 K(0.0%)
Dec 2009
$17.00 K(>+9900.0%)
$17.00 K(>+9900.0%)
Dec 2008
$0.00(-100.0%)
$0.00(-100.0%)
Dec 2007
$900.00 K(-10.0%)
$900.00 K(+125.0%)
Sept 2007
-
$400.00 K(+100.0%)
June 2007
-
$200.00 K(0.0%)
Mar 2007
-
$200.00 K(-80.0%)
Mar 2003
-
$1.00 M(0.0%)
Dec 2002
$1.00 M(-75.0%)
$1.00 M(+110.5%)
Sept 2002
-
$475.00 K(-88.1%)
Dec 2001
$4.00 M(+3900.0%)
$4.00 M(+100.0%)
Sept 2001
-
$2.00 M(+233.3%)
Sept 1999
-
$600.00 K(+500.0%)
Mar 1999
-
$100.00 K(0.0%)
Dec 1998
$100.00 K(-50.0%)
$100.00 K(-50.0%)
Dec 1995
$200.00 K
$200.00 K(+100.0%)
June 1993
-
$100.00 K(-87.5%)
Mar 1993
-
$800.00 K

FAQ

  • What is Theriva Biologics annual short term debt?
  • What is the all time high annual short term debt for Theriva Biologics?
  • What is Theriva Biologics annual short term debt year-on-year change?
  • What is Theriva Biologics quarterly short term debt?
  • What is the all time high quarterly short term debt for Theriva Biologics?
  • What is Theriva Biologics quarterly short term debt year-on-year change?

What is Theriva Biologics annual short term debt?

The current annual short term debt of TOVX is $550.00 K

What is the all time high annual short term debt for Theriva Biologics?

Theriva Biologics all-time high annual short term debt is $4.00 M

What is Theriva Biologics annual short term debt year-on-year change?

Over the past year, TOVX annual short term debt has changed by +$277.00 K (+101.47%)

What is Theriva Biologics quarterly short term debt?

The current quarterly short term debt of TOVX is $606.00 K

What is the all time high quarterly short term debt for Theriva Biologics?

Theriva Biologics all-time high quarterly short term debt is $4.00 M

What is Theriva Biologics quarterly short term debt year-on-year change?

Over the past year, TOVX quarterly short term debt has changed by +$80.00 K (+15.21%)